The primary focus of this ebook is to give an idea about various HDAC and MAPK inhibitors which can be used as chemotherapeutic agents for the treatment of Cancer. This book also gives a general idea about various functions performed by HDAC and MAPK inhibitors. In this book, I have picked 10 inhibitors which are synthesized by Sellek Biochemicals and are
either currently undergoing clinical testing or have already been approved by FDA. This ebook contains 5 MAPK and 5 HDAC Inhibitors and their mechanism of fighting with Cancer Cells.
The following HDAC inhibitors are covered:
- AR-42 (HDAC-42)
- BELINOSTAT (PXD101)
- CUDC-101
- DROXINOSTAT
- Vorinostat (SAHA)
The following MAPK inhibitors are discussed:
- GDC-0879
- PD98059
- PLX-4720
- RAF265
- SB590885
either currently undergoing clinical testing or have already been approved by FDA. This ebook contains 5 MAPK and 5 HDAC Inhibitors and their mechanism of fighting with Cancer Cells.
The following HDAC inhibitors are covered:
- AR-42 (HDAC-42)
- BELINOSTAT (PXD101)
- CUDC-101
- DROXINOSTAT
- Vorinostat (SAHA)
The following MAPK inhibitors are discussed:
- GDC-0879
- PD98059
- PLX-4720
- RAF265
- SB590885